These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27556357)

  • 1. Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer.
    Wan X; Huang W; Yang S; Zhang Y; Pu H; Fu F; Huang Y; Wu H; Li T; Li Y
    Oncotarget; 2016 Sep; 7(37):60503-60518. PubMed ID: 27556357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth.
    Ta HQ; Whitworth H; Yin Y; Conaway M; Frierson HF; Campbell MJ; Raj GV; Gioeli D
    Mol Cancer; 2019 Jun; 18(1):113. PubMed ID: 31253147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.
    Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y
    Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
    Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
    Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
    Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
    Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAT resistance-related AC007405.2 and AL354989.1 as novel diagnostic and prognostic markers in prostate cancer.
    Deng Y; Zhang C; Yu H; Chen G; Peng X; Li Y; Feng Z; Shi W; Bai X; Gou X; Liu N
    Aging (Albany NY); 2024 Apr; 16(8):7249-7266. PubMed ID: 38643469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence.
    Wang L; Han S; Jin G; Zhou X; Li M; Ying X; Wang L; Wu H; Zhu Q
    Int J Oncol; 2014 Jun; 44(6):2041-9. PubMed ID: 24691949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
    Xu YH; Deng JL; Wang G; Zhu YS
    Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs and prostate cancer.
    Misawa A; Takayama KI; Inoue S
    Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of androgen response-related lncRNAs in prostate cancer.
    Karthikeyan SK; Xu N; Ferguson Rd JE; Rais-Bahrami S; Qin ZS; Manne U; Netto GJ; S Chandrashekar D; Varambally S
    Prostate; 2023 May; 83(6):590-601. PubMed ID: 36760203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five lncRNAs Associated With Prostate Cancer Prognosis Identified by Coexpression Network Analysis.
    Gong X; Ning B
    Technol Cancer Res Treat; 2020; 19():1533033820963578. PubMed ID: 33084528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer.
    Böttcher R; Hoogland AM; Dits N; Verhoef EI; Kweldam C; Waranecki P; Bangma CH; van Leenders GJ; Jenster G
    Oncotarget; 2015 Feb; 6(6):4036-50. PubMed ID: 25686826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management.
    Ramnarine VR; Kobelev M; Gibb EA; Nouri M; Lin D; Wang Y; Buttyan R; Davicioni E; Zoubeidi A; Collins CC
    Eur Urol; 2019 Nov; 76(5):546-559. PubMed ID: 31445843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Characterization of Androgen-Responsive lncRNAs Mediated Regulatory Network in Hormone-Related Cancers.
    Wang D; Li M; Li J; Wan X; Huang Y; Wang C; Zhang P; Xu Y; Kong Z; Lu Y; Wang X; Liu C; Ji C; Li L
    Dis Markers; 2020; 2020():8884450. PubMed ID: 33082888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Roles of long non-coding RNAs in prostate cancer and their action mechanisms].
    Li ZF; Xiao N; Yao YW; Yao ZF
    Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1129-1135. PubMed ID: 37846635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression Network Analysis Identifies a Novel Nine-RNA Signature to Improve Prognostic Prediction for Prostate Cancer Patients.
    Cai J; Chen Z; Chen X; Huang H; Lin X; Miao B
    Biomed Res Int; 2020; 2020():4264291. PubMed ID: 32953881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of lncRNA SNHG1 in prostate cancer patients and inhibition of SNHG1 suppresses cell proliferation and promotes apoptosis.
    Tang Q; Li Z; Han W; Cheng S; Wang Y
    Indian J Pathol Microbiol; 2020; 63(4):575-580. PubMed ID: 33154308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression status and prognostic value of autophagy-related lncRNAs in prostate cancer.
    Chen G; Qin X; Wang Y; Gao B; Ling M; Yin W; Li Y; Pan B
    Cell Cycle; 2022 Aug; 21(16):1684-1696. PubMed ID: 35414328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.